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Abstract 
Molecular and genetic definitions of human-specific changes to genomic regulatory networks (GRNs) 
contributing to development of unique to human phenotypes remain a highly significant challenge. Genome-
wide proximity placement analysis of diverse families of human-specific genomic regulatory loci (HSGRL) 
identified topologically-associating domains (TADs) that are significantly enriched for HSGRL and designated 
rapidly-evolving in humans TADs (Genome Biol Evol. 2016 8; 2774-88). Here, the analysis of HSGRL, hESC-
enriched enhancers, super-enhancers (SEs), and specific sub-TAD structures termed super-enhancer domains 
(SEDs) has been performed. In the hESC genome, 331 of 504 (66%) of SED-harboring TADs contain HSGRL 
and 68% of SEDs co-localize with HSGRL, suggesting that emergence of HSGRL may have rewired SED-
associated GRNs within specific TADs by inserting novel and/or erasing existing non-coding regulatory 
sequences. Consequently, markedly distinct features of the principal regulatory structures of interphase 
chromatin evolved in the hESC genome compared to mouse: the SED quantity is 3-fold higher and the median 
SED size is significantly larger. Concomitantly, the overall TAD quantity is increased by 42% while the median 
TAD size is significantly decreased (p = 9.11E-37) in the hESC genome. Present analyses illustrate a putative 
global role for HSGRL in shaping the human-specific features of the interphase chromatin organization and 
functions, which are facilitated by accelerated creation of new enhancers associated with targeted placement 
of HSGRL at defined genomic coordinates. A trend toward the convergence of TAD and SED architectures of 
interphase chromatin in the hESC genome may reflect changes of 3D-folding patterns of linear chromatin 
fibers designed to enhance both regulatory complexity and functional precision of GRNs by creating 
predominantly a single gene per regulatory domain structures.  
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Introduction 
Despite the remarkable progress illustrated by the near-comprehensive catalogue of changes within protein-
coding genes that occurred during human evolution, the genetic and molecular basis defining unique to human 
phenotypic features remains largely unknown. These studies suggested that changes of protein-coding genes 
alone cannot explain most of the unique to human traits (Chimpanzee Sequencing and Analysis Consortium, 
2005; Green et al., 2010; Meyer et al., 2012; Prüfer et al., 2012; 2014; Fu et al., 2014). Therefore, the 
hypothesis that unique to human phenotypes might result from human-specific changes to genomic regulatory 
sequences continues to remain highly relevant (King and Wilson, 1975).  
In recent years, the extensive search for human-specific genomic regulatory loci (HSGRL) has resulted 
in identification of thousands candidate HSGRL, a vast majority of which is located within non-protein coding 
regions of human genome (McLean et al., 2011; Shulha et al., 2012; Konopka et al., 2012; Capra et al., 2013; 
Marnetto et al., 2014; Glinsky, 2015). The rapidly-evolving DNA sequences in humans have been identified 
that are highly conserved across mammals and have acquired many sequence changes in humans since 
divergence from chimpanzees (Pollard et al. 2006; Prabhakar et al. 2006; Bird et al. 2007). Subsequent 
experimental analyses of these sequences, which were designated human accelerated regions (HARs), 
revealed that some HARs function as non-coding RNA genes expressed during the neocortex development 
(Pollard et al. 2006) and human-specific developmental enhancers (Prabhakar et al. 2008). Recent 
computational and bioinformatics analyses and transgenic mouse experiments demonstrated that many HARs 
represent developmental enhancers (Capra et al., 2013).  
Genome-wide analysis of transcription factor binding sites (TFBS) in human embryonic stem cells 
(hESC) demonstrated that transposable element-derived sequences, most notably LTR7/HERVH, 
LTR5_Hs/HERVK, and L1HS, harbor thousands of candidate human-specific TFBS (Glinsky, 2015). A majority 
of these candidate HSGRL appears to function as TFBS for NANOG, POU5F1 (OCT4), and CTCF proteins 
exclusively in hESC, suggesting their critical regulatory role during the early-stage embryogenesis (Glinsky, 
2015). Interestingly, hESC-specific NANOG-binding sites appear enriched near the protein-coding genes 
regulating brain size, pluripotency long non-coding RNAs, hESC enhancers, and 5-hydroxymethylcytosine-
harboring sequences immediately adjacent to TFBS. Consistent with the hypothesis that they contribute to  
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development of human-specific phenotypes, candidate human-specific TFBS are placed near the coding 
genes associated with physiological development and functions of nervous and cardiovascular systems, 
embryonic development, behavior, as well as development of a diverse spectrum of pathological conditions 
such as cancer, diseases of cardiovascular and reproductive systems, metabolic diseases, multiple 
neurological and psychological disorders (Glinsky, 2015-2016). Taken together, these studies lend credence to 
the hypothesis that HSGRL may function in human cells as regulatory DNA sequences.   
Significantly, a constantly expanding catalog of candidate HSGRL includes nearly twenty thousand of 
genomic regulatory elements comprising the following multiple distinct families of HSGRL:   
i) regions of human-specific loss of conserved regulatory DNA termed hCONDEL (McLean et al., 
2011); 
ii) human-specific epigenetic regulatory marks consisting of H3K4me3 histone methylation 
signatures at transcription start sites in prefrontal neurons (Shulha et al., 2012);  
iii) human-specific transcriptional genetic networks in the frontal lobe (Konopka et al., 2012); 
iv) conserved in humans novel regulatory DNA sequences designated human accelerated regions, 
HARs (Capra et al., 2013);  
v) fixed human-specific regulatory regions, FHSRR (Marnetto et al., 2014); 
vi) human-specific transcription factor-binding sites, HSTFBS (Glinsky, 2015); 
vii) DNase I hypersensitive sites (DHSs) that are conserved in non-human primates but accelerated 
in the human lineage (haDHS; Gittelman et al. 2015); 
viii) DNase I hypersensitive sites (DHSs) that are under accelerated evolution, ace-DHSs (Dong et 
al., 2016). 
In the mammalian nucleus, beads on a string linear strands of interphase chromatin fibers are folded 
into continuous megabase-sized structures termed topologically associating domains (TADs) that are readily 
detectable by the high-throughput analysis of interactions of chemically cross-linked chromatin (Dixon et al., 
2012; Hou et al., 2012; Nora et al., 2012; Sexton et al., 2012).  It has been suggested that TADs represent 
evolutionary-conserved spatially-segregated neighborhoods of high local frequency of intrachromosomal 
contacts reflecting the likelihood of individual physical interactions between long-range enhancers and 
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promoters of target genes in live cells (Dixon et al., 2012; Gorkin et al., 2014). Formal definition of TADs 
implies that neighboring TADs are separated by the sharp boundaries, across which the intrachromosomal 
contacts are relatively infrequent (Dixon et al., 2012; Gorkin et al., 2014). A genome-wide proximity placement 
analysis of 18,364 DNA sequences representing multiple diverse families of HSGRL within the context of the 
principal regulatory structures of the interphase chromatin identified a sub-set of TADs that are significantly 
enriched for HSGRL and termed rapidly-evolving in humans TADs (Glinsky, 2016). There are significant 
enrichment within the boundaries of rapidly-evolving in humans TADs (revTAD) of hESC enhancers, primate-
specific CTCF-binding sites, human-specific RNAPII-binding sites, hCONDELs, and H3K4me3 peaks with 
human-specific enrichment at transcription start sites (TSS) in prefrontal cortex neurons. 
The identity of embryonic stem cells (ESC) critically depends on continuing actions of key master 
transcription factors (Young, 2011; Ng and Surani, 2011), which govern the maintenance of the ESC’s 
pluripotency state by forming constitutively active super-enhancers (Hnisz et al., 2013; Whyte et al., 2013; 
Dowen et al., 2014). Recent experiments show that regulation of pluripotency in ESC occurs within selected 
TADs by establishing specific sub-TAD structures designated super-enhancer domains (Dowen et al., 2014). 
Super-enhancer domains (SEDs) are formed by the looping interactions between two CTCF-binding sites co-
occupied by cohesin. In ESC, TADs and SEDs are designed to isolate super-enhancers (SEs) and target 
genes within insulated genomic neighborhoods to facilitate the functional precision of regulatory interactions 
between key genetic elements: SE, SE-driven cell identity genes and repressed genes encoding lineage-
specifying developmental regulators (Dowen et al., 2014). Precise nature of structural-functional relationships 
between the HSGRL and principal structural elements of the interphase chromatin defining a spatial 
architecture of the pluripotency regulatory network in hESC remains unexplored.  
Results of the present analyses revealed novel insights into structural-functional features of HSGRL of 
potential mechanistic significance that may have contributed to the marked changes of the interphase 
chromatin structure in the human genome, which are exemplified by the increased number and reduced size of 
TADs. Importantly, the concomitant HSGRL-associated increase of both the quantity and size of SEDs was 
documented in the hESC genome. Collectively, these observations identify the increasing of both regulatory 
complexity and functional precision of genomic regulatory networks due to convergence of TAD and SED 
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architectures as one of the main trend of the interphase chromatin structural changes driven by the HSGRL 
during the evolution of H. sapiens.  
 
Results 
 
Markedly distinct features of super-enhancers in the hESC genome compared with mESC 
The sustained expression of key cell identity genes and repression of genes encoding lineage-specifying 
developmental regulators is essential for maintaining ESC identity and pluripotency state. These processes are 
governed by the master TFs OCT4 (POU5F1), SOX2, and NANOG (OSN), that function by establishing SEs 
regulating cell identity genes, including master TFs themselves ((Hnisz et al., 2013; Whyte et al., 2013). The 
spatial relationships between SEs and HSGRL in the hESC genome within the context of TADs have not been 
investigated. To this end, the placement enrichment analysis was carried out to identify all TADs in hESC 
genome that harbor SEs and examine the association of SEs and HSGRL. There are 504 TADs (16%) 
harboring 642 SEs (94%) in the hESC genome. Remarkably, significant placement co-enrichments were 
observed between SEs, HSTFBS, and HARs residing within the boundaries of 279 TADs in the hESC genome 
(Table 1). In total, 279 TADs (8.9%) harbor 369 SEs (57.5%) that are co-localized with 300 HSTFBS and 564 
HARs. When other HSGRL families (Glinsky, 2016) were considered in co-localization analyses, 331 TADs 
(10.6%) harboring 436 SEs (67.9%) were found to co-localize with HSGRL.  
In human genome, there are approximately 7,000 high-confidence hESC-enriched enhancers (Xie et 
al., 2013; Hnisz et al., 2013), less than 10% of which are defined as SEs (Hnisz et al., 2013). Placement of 
high-confidence hESC enhancers is significantly enriched within the revTADs (Glinsky, 2016), implying 
possible genome-wide associations of HSGRL and hESC-enriched enhancers. Indeed, such associations 
became apparent when genomic co-localization analyses were performed to assess numbers of HSGRL and 
hESC-enriched enhancers residing within the boundaries of TADs. These analyses revealed that there is a 
significant direct correlation between the numbers of hESC-enriched enhancers and HARs that are located 
within the same revTADs (Fig. 1). Genome-wide placement and/or retention of HARs appears enriched within 
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hESC enhancer-harboring TADs and seems to favor TADs containing larger numbers of hESC-enriched 
enhancers (Fig. 1).  
Co-localization of a majority of SEs with HSGRL suggest that HSGRL may affect the structural-
functional features of SEs in the hESC genome. Consistent with this hypothesis, genomes of human and 
mouse ESC manifest markedly distinct features associated with SE structures and functions. Despite strikingly 
similar genome sizes and numbers of protein-coding genes, hESC genome contains 3-fold more SEs 
compared to mouse: there are 684 SEs in the genome of hESC (Hnisz et al., 2013) and 231 SEs in the 
genome of mESC (Whyte et al., 2013). In the genome of hESC, only twenty-five of mESC SEs (11%) are 
represented as conserved orthologous sequences having genomic architecture of SEs, suggesting that 89% of 
mESC SEs lost the SE features in humans. Furthermore, 96% of SEs in the genome of hESC acquired 
structural-functional features of SEs during evolution after Euarchonta and Glires split 88 million years ago. 
The median size of SEs in hESC appears significantly larger compared to the median SE size in mESC ((9,589 
bp versus 8,667 bp, respectively; p = 0.017). Detailed size distribution analyses demonstrated that 
accumulation of SEs in hESC genome is associated with increased number of large SEs and decreased 
number of small SEs compared to mouse genome: there are 7-fold increase of very large SEs having size 
more than 30 Kb, consistent ~3-fold increase of SEs having size range from 2 – 30 Kb, and a marked 38-fold 
depletion of small SEs having size less than 2 Kb (Table 2; Fig. 2).  
Collectively, these data indicate that structural-functional features of SEs are markedly distinct in the 
hESC genome compared to the mouse, which appear associated with the enrichment of HSGRL within SE-
harboring TADs. It will be of interest to determine whether the HSGRL placement within SE-harboring TADs 
exerts biologically-meaningful effects on SE functions. Targeted placements and/or retention of HSGRL may 
increase density of enhancer elements within selected TADs, which would result in the merger of conventional 
enhancer units into super-enhancer structures containing the exceptionally high level of transcription-enabling 
apparatus to drive and continually maintain high expression of associated target genes. This idea is supported 
by the findings that nearly 60% (1571) of the HARs overlap at least one of the common markers of enhancer 
activity in human cells (Capra et al., 2013).  
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TAD structural features are markedly altered in the hESC genome compared with mESC 
There are 3,127 TADs in the hESC genome, which is 42% more than 2,200 TADs in the genome of mESC 
(Dixon et al., 2012). Correspondingly, there are 87,883 CTCF-binding sites in hESC (Kunarso et al., 2010), 
29,018 (33%) of which represent primate-specific CTCF-binding sequences (Glinsky, 2015). The median size 
of TADs in hESC is significantly smaller compared to the median size of TADs in mESC (680 Kb versus 880 
Kb; p = 9.11E-37). Detailed size distribution analyses of TADs in human and mouse ESC (Fig. 2; Table 3) 
revealed that there is a ~ 2-fold depletion of large TADs having size > 2,000 Kb and consistently increased 
numbers of medium-size and small TADs having size range from 100 - 1,000 Kb (Table 3). Structural-
functional features of the revTADs in the hESC genome appear markedly distinct from the TADs of the 
orthologous sequences in the mouse ESC genome. Of the 60 revTAD (Glinsky, 2016), nineteen (32%) are 
placed within the primate-specific sequences that failed to align to the mouse reference genome database 
sequence. Remaining revTADs appear to evolve by erasing the existing and establishing new domain 
boundaries within orthologous DNA sequences via two distinct mechanisms: 1) domain & boundary crossing 
(hESC TADs appear to cross boundaries of 2 to 4 orthologous TADs in mESC genome); and 2) domain 
shrinking & boundary creation (smaller hESC TADs are placed within the boundaries of larger orthologous 
TAD sequences in mESC genome).  
The above considerations prompted additional analyses of relationships between the SEs and TADs in 
the genomes of human and mouse ESC (Fig. 3). These analyses revealed that in hESC there are significant 
direct correlations between the size of TADs and SE’s span defined as a number of bp between the two most 
distant SEs located within a given TAD (Fig. 3A). Similar trends were observed in the mESC genome, 
however, the correlation coefficient values were not statistically significant. Correlation patterns observed for 
the 60 revTADs for placements of hESC-enriched enhancers, HARs, HSTFBS, and size of TADs were 
validated on a larger set of 147 revTADs (Fig. 3B). Genome-wide, the highly significant direct correlation was 
discovered between the size of TADs and the number of hESC-enriched enhancers located within TADs (Fig. 
3C). These observations are conceptually coherent because TAD boundaries were inferred from the relative 
prevalence and directionality of interchromosomal interactions along the chromosome length (Dixon et al., 
2012), which are predominantly mediated by the enhancers’ activities and detected as enhancer-promoter and 
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enhancer-enhancer interactions in the Hi-C analyses. It will be of interest to determine experimentally whether 
the size and boundaries of the adjacent and neighboring TADs can be altered by increasing the density, 
structure, and activity of the resident enhancers.  
 
Potential mechanisms of HSGRL-mediated effects on principal regulatory structures of interphase 
chromatin 
Present analyses provide a conceptual framework for understanding genome-scale regulatory changes during 
evolution within the context of the principal regulatory structures of the interphase chromatin to reflect an 
apparent trend toward increasing complexity of genomic regulatory networks (Fig. 4). Experimental 
observations at the foundation of building blocks of the genome’s evolution model are described in the 
previous sections and additional considerations are focused on the analyses of potential contributions of 
hESC-enriched enhancers, SEs, and SEDs to these processes. 
 According to the model, one of the key elements of the evolution of genomic regulatory networks is the 
creation of new enhancer elements (Fig. 4). Conventional enhancers comprise discrete DNA segments 
occupying a few hundred base pairs of the linear DNA sequence and harboring multiple TFBS. SEs consist of 
clusters of conventional enhancers that are densely occupied by the master transcription factors and Mediator 
(Whyte et al., 2013). Therefore, it is logical to expect that creation of new TFBS and increasing density of 
TFBS would increase the probability of the emergence of new enhancer elements. It follows that creation of 
new enhancers and increasing their density would facilitate the emergence of new SE structures. This 
sequence of events would imply that evolutionary time periods required for creation of TFBS, enhancers, and 
SEs are shortest for TFBS, intermediate for enhancers, and longest for SEs. To test this assumption, estimates 
of creation time periods for enhancers and SEs in the hESC genome were calculated (Table 4) and compared 
to the previously reported estimates of creation time periods of TFBS (Glinsky, 2015). Consistent with the 
model expectations, the estimated creation time is markedly longer for SEs compared to enhancers for 
conserved (8-fold), primate-specific (17-fold), and human-specific (63-fold) regulatory sequences (Table 4). 
Furthermore, the estimated creation time periods for enhancers appear several fold longer compared to the 
creation time estimates for TFBS sequences in both chimpanzee and humans (Glinsky, 2015). One of the 
 11 
 
intriguing results of this analysis is that 87% of new SEs and 75% of new enhancers in the hESC genome were 
created within conserved sequences (Table 4). Similarly, a majority (67%) of new binding sites for NANOG 
(59,221 of 88,351 TFBS) and CTCF (58,865 of 87,883 TFBS) proteins in the hESC genome compared with 
mESC are located within conserved sequences (Supplemental Fig. S3).  
Notably, the estimated creation time appears accelerated in humans compared to chimpanzee for both 
SEs (7-fold) and enhancers (27-fold), suggesting that human genomes were acquiring new regulatory 
elements and increasing the regulatory complexity and precision of genomic regulatory networks at the 
markedly accelerated pace.  
 CTCF-binding sites play a crucial role in defining the TAD boundaries (Dixon et al., 2012; Li et al., 
2013) and in establishing the SED architecture (Dowen et al., 2014). Knocking down the expression of CTCF 
and cohesin genes to reduce their protein concentrations results in a decrease in the number of intra-TAD 
chromatin loops (Sofueva et al., 2013; Seitan et al., 2013; Zuin et al., 2014), increase in the number of inter-
TAD chromatin interactions crossing the TAD boundaries (Zuin et al., 2014), and chromatin compaction (Tark-
Dame et al., 2014). Several lines of evidence are in agreement with the hypothesis that creation of new CTCF-
binding sites may have contributed to the rewiring of interphase chromatin architecture and genomic regulatory 
networks during primate evolution: 
i) In the hESC genome, 29,018 of 87,883 (33%) CTCF-binding sites represent primate-specific 
sequences (Kunarso et al., 2010; Glinsky, 2015); 
ii) Of the 23,709 constitutive CTCF-binding sites implicated in defining TAD boundaries in the human 
genome (Li et al., 2013), 6,787 sites  (28.6%) failed alignment to the mouse genome, suggesting 
that they represent primate-specific sequences;  
iii) Two hundred eighty seven HARs (10.5%) are located within 10 Kb of the 336 constitutive CTCF-
binding sites; 
iv) Five hundred seventy one HARs (20.8%) are located within 1 Kb of 953 CTCF-binding sites; 
v) Activation of retrotransposons and lineage-specific repeat-driven dispersion of CTCF-binding sites 
has produced species-specific expansions of CTCF binding in mammalian genomes and these new 
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CTCF-binding sites function as chromatin domain insulators and transcriptional regulators (Schmidt 
et al., 2012).  
Detailed proximity placement and HARs/TFBS co-localization analyses identified 123 HARs located 
within 1 Kb from 127 high-confidence CTCF-binding sites, which were validated in 23 different human cells 
lines. Notably, 123 of 127 (97%) high-confidence CTCF-binding sites represent overlapping CTCF/RAD21-
binding sites, which is consistent with their putative regulatory role in establishing TAD boundaries and/or SED 
architecture. A significant majority of 123 HARs located near high-confidence overlapping CTCF/RAD21-
binding sites harbor at least one TFBS in human cells (76 HARs; 62%).  
Significant increase of TAD and SED numbers in human genomes compared with mouse indicates that 
chromatin folding profiles are dramatically altered, reflecting more frequent intrachromosomal segmentation of 
linear DNA fibers and enhanced likelihoods of formation of isolated intra-segmental looping structures. These 
changes of chromatin folding profiles and DNA fibers’ packaging patterns would impose more stringent 
requirement on DNA elasticity, particularly, near the TAD and SED boundaries due to bending of DNA double 
helix. Consequently, changes of DNA sequence and/or chromatin structure may be necessary to 
accommodate these new structural requirements. It has been reported that SINE repeats are enriched at the 
TAD boundaries (Dixon et al., 2012), suggesting that insertion of repetitive elements may contribute to 
changes of DNA elasticity near putative bending sites. Consistent with this hypothesis, a survey of SED 
sequences in hESC revealed an apparent systematic placement of Alu elements within ~5 Kb windows near 
SED boundaries (Fig. 5). Clusters of closely-spaced sequences of at least three Alu elements belonging to 
most ancient AluJ (~65 million years old), second oldest AluS (~30 million years old), and currently active 
modern AluY sub-families (Bennett et al., 2008) were observed frequently, suggesting that placement and/or 
retention of Alu elements at these sites were occurring for millions of years and continues at the present time. 
Taken together with the recent report that nearly 60% of the HARs overlap at least one of the common 
markers of enhancers in human cells (Capra et al., 2013), these observations strongly argue that creation of 
new enhancer elements is one of the key events defining evolution of genomic regulatory networks. Marked 
acceleration of the TFBS and enhancers’ creation processes in humans may have contributed to genome-
scale rearrangements of principal regulatory structures of the interphase chromatin, leading to the increased 
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complexity and enhanced precision of genomic regulatory networks and emergence of human-specific 
phenotypes. Frequent locations of Alu sequences near the putative DNA bending sites suggest their potential 
role in regulation of the elasticity of chromatin fibers by reducing nucleosome placements due to the low affinity 
of Alu elements to nucleosome binding (Huda et al., 2009) and/or facilitating strand invasion reactions between 
neighboring DNA strands leading to Alu/Alu recombination events (Lee at al., 2015; Morales et al., 2015). This 
model is in agreement with the observations that Alu elements appear preferentially retained in GC-rich and 
gene-rich regions of the human genome (Lander et al., 2001).  
 
Conservation patterns of HSGRL in individual human genomes 
All analyses conducted so far were performed using the reference genome databases and not the individual 
human genomes. To address this limitation, the assessment of conservation of HSGRL in individual genomes 
of 3 Neanderthals, 12 Modern Humans, and the 41,000-year old Denisovan genome (Reich et al., 2010; Meyer 
et al., 2012) was carried-out by direct comparisons of corresponding sequences retrieved from individual 
genomes and the human genome reference database (http://genome.ucsc.edu/Neandertal/ ). Full-length 
sequence alignments with no gaps of the individual genome sequences to the corresponding sequences in the 
human genome reference databases of both hg18 and hg19 releases were accepted as the evidence of 
sequence conservation in the individual human genome.  
Sequences of all analyzed to date HSGRL appear conserved in individual human genomes (Fig. 6 and 
Supplemental Fig. S4), albeit a significant inter-individual variability in degree of conservations of specific 
HSGRL is apparent. Conservation of all HSGRL are consistently at the lowest level in the Neanderthals’ 
genome, suggesting that creation and/or retention rates of HSGRL are enhanced in Modern Humans. The 
results of these analyses indicate that sequences of HSGRL with assigned biochemical functions, e.g., specific 
TFBS or Lamin B1 (LMNB1)-binding sites, which are residing within HARs, exhibit markedly higher 
conservation levels compared to sequences of HARs harboring the corresponding HSGRL. This conclusion 
remains valid for HSGRL sequences with assigned specific biochemical or biological functions that were 
associated with HARs by proximity placement analyses (Figs. 6A, B). HSGRL sequences manifesting the 
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relatively high conservation levels in the Neanderthals’ genome appear most conserved in the individual 
genomes of Modern Humans as well, including the 41,000-year old Denisovan genome (Fig. 6B).  
Consistent patterns of significant direct correlations between conservation profiles of distinct seemingly 
unrelated HSGRL sequences in individual human genomes were observed (Fig. 6C and Supplemental Fig. 
S4). One possible interpretation of these observations is that HSGRL conservation patterns reflect intrinsic 
features of the individual human genome, integration of which can gauge the overall capacity of a genome to 
create and retain HSGRL. This idea was tested by calculating for each individual human genome the genomic 
fitness scores integrating into a single numerical value sequence conservation data of 909 HSGRL (Fig. 6C; 
bottom panel). Notably, individual human genomes appear markedly distinct based on the results of this 
analysis with the lowest genomic fitness score of 0.9 in Neanderthals, followed by the scores of 1.89; 2.22; and 
2.27 for individual genomes of Native American, Denisova cave, and Mongolian subjects, respectively. On the 
other end of the spectrum, the genomic fitness scores of 4.51; 4.72; and 4.73 were obtained for genomes of 
Yoruba (West Africa), French (Western Europe), and San (Southern Africa) individuals, respectively.  
These observations are highly congruent with the recent definition of structural variations-free (fixed) 
human-specific regulatory regions (FHSRR) based on the stringent formal analysis of the HSGRL intra-species 
patterns of variations within human population using exome and full genome sequencing database of 1,092 
individuals from the 1000 Genomes Project Consortium (Abecasis et al., 2012; Marnetto et al., 2014). 
Collectively, the consistent evidence of HSGRL conservation in individual human genomes are in accord with 
the hypothesis of their putative functional role in defining human-specific phenotypes.  
 
Discussion 
Placing several meters of linear DNA fibers into micron-sized nucleus while maintaining the genome integrity 
and ensuring the functional precision of genomic regulatory networks represent a set of formidable challenges 
successfully addressed during the evolution of eukaryotes. The elegant evolutionary solutions to these 
problems are illustrated by the recent pioneering work on the 3D structures of interphase chromosomes. These 
studies revealed specific folding patterns of the linear chromosome fibers into spatially-segregated domain-like 
segments experimentally-defined as the continuous megabase-sized topologically associating domains 
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(TADs). TADs are readily and reproducibly detectable by the high-throughput analysis of inter-chromosomal 
interactions of chemically cross-linked chromatin (Dixon et al., 2012; Hou et al., 2012; Nora et al., 2012; Sexton 
et al., 2012). It has been suggested that one of the principal creative events in the continuing chromatin 
domain architecture remodeling process during human evolution is the HSGRL-enabled emergence of new 
enhancer elements (Glinsky, 2016-2017), increasing density of which would enhance the probability of 
structural transition from conventional enhancers to novel SE structures and the subsequent formation of new 
SEDs (Fig. 4). Significantly, primate-specific and human-specific sequences appear to contribute to creation of 
interacting pairs of conserved and/or newly created overlapping CTCF/cohesin-binding sites flanking novel 
SEs, which represents the essential structural requirement for the formation of functional SEDs. On the 
evolutionary scale, these processes involve continuing removal of old and creation of new regulatory 
sequences through multiple trial-and-error events enabled by retrotransposition, cytosine MADE, and 
recombination (Glinsky, 2015-2016). Collectively, the ensemble of these HSGRL-associated changes of the 
nuclear regulatory architecture may facilitate the enhanced precision of regulatory interactions between 
enhancers and target genes within specifically reconstructed insulated SED neighborhoods and rewired 
genome-wide TAD networks. Taken together, these observations imply that the convergence of TAD and SED 
architectures, which is exemplified in the human genome by concomitant processes of increasing both quantity 
and size of SEDs and the increasing number and size reduction of TADs, might represent one of the main 
directions of the interphase chromatin structural changes during the evolution of genomic regulatory networks.  
Recent studies documented several human-specific features of the interphase chromatin architecture, 
evolution of which appear associated with the targeted placement and/or retention of HSGRL. Genome-wide 
proximity placement analyses of 18,364 DNA sequences representing distinct families of HSGRL identified a 
small fraction of TADs in the human genome, which manifest a statistically significant accumulation of HSGRL 
compared to the expected values estimated based on a random distribution model (Glinsky, 2016). This set of 
TADs, termed rapidly-evolving in humans TADs (revTADs), acquired the maximum enrichment levels of 16-fold 
for HARs; 17-fold for hESC-FHSRRs; 50-fold for HSTFBS; and 88-fold for DHS-FHSRRs (p < 0.0001 in all 
instances; Glinsky, 2016). Follow-up analyses of sixty revTADs, which were defined based on the enrichment 
of HARs and HSTFBS, revealed that all reported to date HSGRL and human-specific epigenetic signatures 
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associated with embryonic development appear significantly enriched within the revTAD boundaries (Glinsky, 
2016). One of the features of revTADs was revealed by the correlation analyses of HARs and HSTFBS: 
placements of different types of HSTFBS manifest significant positive correlations, whereas placements of 
HARs and HSTFBS exhibit inverse correlation profiles (Glinsky, 2016). Consistent with the hypothesis of the 
increased precision of genomic regulatory networks during evolution, a majority of revTADs in human genome 
tend to harbor a small number of coding genes: 65% of revTADs contain five or less protein-coding genes, 
among which eight revTADs harbor just one protein-coding gene and two revTADs contain only non-coding 
RNA genes. Several revTADs contain large clusters of functionally-related protein-coding genes: three 
revTADs on chr11 harbor 61 genes encoding olfactory receptors; three consecutively-spaced revTADs on 
chr19 harbor 31 genes encoding zinc finger proteins; and one revTAD on chr20 contains eight beta-defensins’ 
genes. Overview of the RNAseq data documented two other features of revTADs: i) clearly discernable tissue-
specific patterns of non-coding RNA expression; and ii) a prominent presence of non-coding RNA transcripts in 
human brain regions.  
Correlation screens of proximity placement patterns of different HSGRL residing within the revTADs 
revealed markedly distinct correlation profiles of individual members of HSGRL families and recombination 
rates within the host revTADs. These analyses readily distinguish placement patterns of HARs and HSTFBS: 
revTADs having high recombination scores tend to accumulate large numbers of HARs while revTADs with low 
recombination scores harbor high numbers of HSTFBS (Glinsky, 2016). Consistent with the requirements of 
DNA strand interactions and strand invasion for the recombination process, significant direct correlations were 
observed between recombination scores and intra-chromosomal contacts within revTADs (Glinsky, 2016). 
Therefore, placements of HARs and HSTFBS within revTADs appear associated with distinct molecular 
processes. Placement of HARs within revTADs exhibits significant positive correlation with high recombination 
rates, which seems to connect the biogenesis of HARs with recombination mechanisms. In contrast, significant 
inverse correlation between HSTFBS placement and recombination rates as well as location of 99% of 
HSTFBS within TE – derived DNA sequences (Glinsky, 2015) strongly implicate TE activity in the biogenesis of 
HSTFBS. Since HARs by definition are located within highly evolutionary conserved DNA sequences, results 
of these analyses suggest that molecular mechanisms driving the emergence of regulatory loci evolved by 
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exaptation of ancestral DNA (Cotney et al., 2013; Villar et al., 2015) may be associated with meiotic 
recombination as well.  
One of the notable features of potential mechanistic significance is the association of hESC-enriched 
enhancers and SEDs with HSGRL (Table 1). Taking into account that there are ~4,000 HSTFBS in the hESC 
genome (Glinsky, 2015) and nearly 60% of HARs overlap at least one of the common markers of enhancers in 
human cells (Capra et al., 2013), it seems logical to propose that creation of new enhancer elements leading to 
increasing density of conventional enhancers in selected genomic regions is one of the key events defining the 
increasing genomic complexity as the main direction of evolution of GRNs. Consistent with this idea, there are 
significant direct correlations between the placements within TADs of HARs and hESC-enriched enhancers 
(Fig. 1), indicating that there is an apparent trend of the placement preference of HARs within TADs harboring 
hESC-enriched enhances. It follows, that higher density of conventional enhancers would increase the 
probability of local structural transitions of chromatin architecture to SEs and SEDs, provided other local 
structural requirements are in place or co-evolved (see below). In agreement with this model, there are 3-fold 
more SEs in the hESC genome compared with the mESC and the median size of hESC SEs is significantly 
larger (Fig. 2).  
Concomitantly, marked changes of TAD structural features in the hESC genome compared with mESC 
were observed, which are particularly striking for revTADs. Genome-wide, there are 42% more TADs in the 
hESC genome and the median size of hESC TADs is significantly smaller (Fig. 2). These changes of TAD 
structural features remain consistent when the corresponding comparisons were made between the similar in 
size individual human and mouse chromosomes (Fig. 2), indicating that hESC genome contains the increased 
number of the predominantly smaller size TADs. Consistent with these observations, comparisons of the high-
resolution 3D maps of human and mouse genomes, which were recently obtained by Rao et al. (2014) using in 
situ Hi-C at a resolution range of 1 – 5 Kb, revealed that there are ~3-fold more contact domains formed by the 
concomitantly increased numbers of long-range chromatin loops in the human GM12878 B-cell lymphoblasts 
compared with the mouse CH12 B-cell lymphoblasts (Rao et al., 2014).  
In the hESC genome, structural changes of the revTADs seem particularly evident: 32% of revTADs 
are located within primate-specific genomic regions and the remaining revTADs appear evolved via 
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mechanisms of boundary crossing, domain mergers, and creation of new boundaries within larger TADs of 
orthologous mouse sequences. Collectively, this dramatic changes of the regulatory infrastructure of 
interphase chromatin can be explained by the model of convergence of TAD and SED architecture (Fig. 4). 
According to this model, the high density of conventional enhancers increases the likelihood of transition to 
larger in size SE structures, formation of new SEDs, and increasing segmentation of genomic regions into 
insulated regulatory neighborhoods of large SED/small TAD structures. Consistent with this model, significant 
correlations were observed between the size of TADs and genomic span of hESC SEs residing within TADs 
(Fig. 3A). There are significant direct correlations between the revTAD sizes and the numbers of hESC-
enriched enhancers residing within revTADs (Fig. 3B). Genome-wide, the highly significant direct correlation 
was observed between the size of TADs and the number of hESC-enriched enhancers located within TADs 
(Fig. 3C).  
In addition to enabling the creation of new enhancer elements, increasing density of conventional 
enhancers, and facilitating transition to SED structures, potential mechanisms of HSGRL-mediated effects on 
principal regulatory structures of interphase chromatin are likely involve emergence of overlapping 
CTCF/cohesin sites and LMNB1-binding sites as well as continuing insertion of Alu clusters near the putative 
DNA bending sites (Figs. 4 & 5). Collectively, the ensemble of these structural changes facilitated by the 
targeted placements and retention of HSGRL at specific genomic locations would enable the emergence of 
new SED structures and remodeling of existing TADs to drive evolution of GRNs (Fig. 4). Presented models of 
dynamic transitions of the interphase chromatin principal regulatory structures are in accord with the results of 
recent high-resolution in situ Hi-C experiments demonstrating that human genomes are partitioned into contact 
domains consisting of ~10,000 loops accommodating functional links between enhancers and promoters (Rao 
et al., 2014). Consistent with the idea that chromatin loops frequently demarcate the boundaries of contact 
domains, anchors at the loop bases typically occur at the contact domain boundaries and involve binding of 
two CTCF/cohesin sites in a convergent orientation with the asymmetric binding motifs of interacting sites 
aligned to face each other (Rao et al., 2014).  
Compelling evidence of conservation in individual human genomes of different families of HSGRL 
(Marnetto et al., 2014; Glinsky, 2015; 2016 Fig. 6; Supplemental Fig. S4) are in accord with the hypothesis of 
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their putative functional role in defining human-specific phenotypes. Observations of highly consistent patterns 
of significant direct correlations between conservation profiles of distinct seemingly unrelated HSGRL 
sequences in individual human genomes were observed (Fig. 6C and Supplemental Fig. S4) suggest that 
HSGRL conservation patterns reflect intrinsic features of the individual human genome, integration of which 
can help to assess the overall capacity of a genome to create and retain HSGRL. In light of emerging evidence 
highlighting the role of HSGRL in development of therapy-resistant malignancies (Glinsky, 2015-2016), it will 
be of interest to explore experimentally the potential practical utility of the outlined herein concepts by building 
and validating the working models of defined super-enhancers’ domains and associated TAD structures in the 
hESC genome (Glinsky, 2017).  
 
Concluding remarks 
In general terms, chromosomes can be viewed as the physical conduits of genetic information enabling its 
secure storage, maintenance, transfer, and efficient translation into a diverse spectrum of specific phenotypes. 
To a large degree all these processes are facilitated by the linear code of DNA sequences and enabled by the 
chromatin structures defining a 3D architecture of interphase chromosomes, which can be considered 
collectively as the chromatin folding code. Present analyses suggest that increasing regulatory complexity in 
human genomes associated with targeted placements of many thousands of HSGRL has a major effect on the 
principal regulatory structures of interphase chromatin, namely TADs, SEs, and SEDs, perhaps, contributing to 
the creation of human-specific chromatin folding code. Recently reported half-lives and mean-lifetimes of 
enhancers were estimated at 296 and 427 hundred million years, respectively (Villar et al., 2015). 
Comparisons of these estimates with the estimates of time periods required for creation of enhancers and SEs 
(Table 4) seem to indicate that new enhancer elements are created at a markedly faster pace compared with 
their decay time span. This marked evolutionary dichotomy of time period requirements for creation of new 
enhancers compared to the enhancers’ loss provides an underlying mechanism explaining why the increasing 
genomic complexity represents a major trend during the evolution of genomic regulatory networks.  
 Exaptation of ancestral DNA was identified as a main mechanism of creation of human-specific 
enhancers active in embryonic limb (Cotney et al., 2013) and as a prevalent creation mechanism of recently 
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evolved enhancers during the mammalian genome evolution (Villar et al., 2015). Consistently, a vast majority 
of distinct classes of regulatory elements in the hESC genome appears created on conserved DNA sequences 
(Table 4; Supplemental Fig. S3), suggesting that exaptation of ancestral DNA constitutes a main mechanism 
of creation of new regulatory sequences in the human genome. Significantly, exaptation of ancestral DNA 
appears to generate overall many more recently evolved regulatory sequences than can be attributed to the 
repeat-driven expansion mechanisms. Therefore, these observations provide further support to the hypothesis 
that meiotic recombination is the predominant mechanism responsible for creation of new regulatory loci during 
evolution.    
The concept of evolution of evolvability posits that a genotypic feature evolves not due to its functional 
effect, but due to its effect on the ability of DNA to evolve more quickly (Wagner and Altenberg, 1996). 
Considering the evolution of enhancers as an example of evolution of evolvability (He et al., 2012; Duque et 
al., 2014) and taking into account the potential role of HSGRL in creation of human-specific networks of 
enhancers, SEs, and SEDs, the apparent mechanistic links of these processes to several key enzymatic 
systems should be regarded as highly promising novel molecular targets of potential therapeutic significance. 
Of particular relevance in this context is the idea that the regulatory balance of HAT and HDAC activities at 
specific genomic loci as well as the performance of enzymatic systems regulating cytosine recovery/methyl-
cytosine deamination cycles and DNA recombination processes may play a major role during the evolution of 
regulatory DNA sequences and emergence of genomic regulatory networks controlling unique to human 
physiological and pathological phenotypes. Emerging evidence implicating HSGRL derived from stem cell-
associated retroviral sequences in the pathogenesis of clinically-lethal human malignancies (Glinsky, 2015-
2016) seem particularly intriguing in this regard.  
 
Materials and Methods 
 
Data Sources and Analytical Protocols 
Solely publicly available datasets and resources were used for this analysis as well as previously reported 
methodological approaches and computational pipelines validated for discovery of primate-specific gene and 
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human-specific regulatory loci (Tay et al., 2009; Kent, 2002; Schwartz et al., 2003; Capra et al., 2013; Marnetto 
et al., 2014; Glinsky, 2015). The analysis is based on the University of California Santa Cruz (UCSC) LiftOver 
conversion of the coordinates of human blocks to corresponding non-human genomes using chain files of pre-
computed whole-genome BLASTZ alignments with a minMatch of 0.95 (unless specified otherwise) and other 
search parameters in default setting (http://genome.ucsc.edu/cgi-bin/hgLiftOver). Extraction of BLASTZ 
alignments by the LiftOver algorithm for a human query generates a LiftOver output “Deleted in new”, which 
indicates that a human sequence does not intersect with any chains in a given non-human genome. This 
indicates the absence of the query sequence in the subject genome and was used to infer the presence or 
absence of the human sequence in the non-human reference genome. Human-specific regulatory sequences 
were manually curated to validate their identities and genomic features using a BLAST algorithm and the latest 
releases of the corresponding reference genome databases for time periods between April, 2013 and June, 
2015.  
Genomic coordinates of 3,127 topologically-associating domains (TADs) in hESC; 6,823 hESC-
enriched enhancers; 6,322 conventional and 684 super-enhancers (SEs) in hESC; 231 SEs and 197 SEDs in 
mESC were reported in the previously published contributions (Dixon et al., 2012; Xie et al., 2013; Hnisz et al., 
2013; Whyte et al., 2013; Dowen et al., 2014). The primary inclusion criterion for selection of the human-
specific genomic regulatory loci (HSGRL) analyzed in this contribution was the fact that they were identified in 
human cells lines and primary human tissues whose karyotype were defined as “normal”. The following four 
HSGRL families comprising of 10,598 individual regulatory DNA sequences were analyzed in this study: 1) 
Human accelerated regions (HARs; Capra et al., 2013); 2) Human-specific transcription factor-binding sites 
(HSTFBS; Glinsky, 2015); 3) hESC-derived fixed human-specific regulatory regions (hESC-FHSRR; Marnetto 
et al., 2014); 4) DNase hypersensitive sites-derived fixed human-specific regulatory regions (DHS-FHSRR; 
Marnetto et al., 2014). The number of HSGRL placed within a given TAD was computed for every TAD in the 
hESC genome and the HSGRL placement enrichment was calculated as the ratio of observed values to 
expected values estimated from a random distribution model at the various cut-off thresholds. Datasets of 
NANOG-, POU5F1-, and CTCF-binding sites and human-specific TFBS in hESCs were reported previously 
(Kunarso et al., 2010; Glinsky, 2015) and are publicly available. RNA-Seq datasets were retrieved from the 
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UCSC data repository site (http://genome.ucsc.edu/; Meyer et al., 2013) for visualization and analysis of cell 
type-specific transcriptional activity of defined genomic regions. A genome-wide map of the human methylome 
at single-base resolution was reported previously (Lister et al., 2009; 2013) and is publicly available 
(http://neomorph.salk.edu/human_methylome). The histone modification and transcription factor chromatin 
immunoprecipitation sequence (ChIP-Seq) datasets for visualization and analysis were obtained from the 
UCSC data repository site (http://genome.ucsc.edu/; Rosenbloom et al., 2013). Genomic coordinates of the 
RNA polymerase II (PII)-binding sites, determined by the chromatin integration analysis with paired end-tag 
sequencing (ChIA-PET) method, were obtained from the saturated libraries constructed for the MCF7 and 
K562 human cell lines (Li et al., 2012). Genome-wide maps of interactions with nuclear lamina, defining 
genomic coordinates of human and mouse lamin-associated domains (LADs), were obtained from previously 
published and publicly available sources (Guelen et al., 2008; Peric-Hupkes et al., 2010). The density of TF-
binding to a given segment of chromosomes was estimated by quantifying the number of protein-specific 
binding events per 1-Mb and 1-kb consecutive segments of selected human chromosomes and plotting the 
resulting binding site density distributions for visualization. Visualization of multiple sequence alignments was 
performed using the WebLogo algorithm (http://weblogo.berkeley.edu/logo.cgi ). Consensus TF-binding site 
motif logos were previously reported (Kunarso et al., 2010; Wang et al., 2012; Ernst and Kellis, 2013).  
The quantitative limits of proximity during the proximity placement analyses were defined based on 
several metrics. One of the metrics was defined using the genomic coordinates placing HSGRL closer to 
putative target protein-coding or lncRNA genes than experimentally defined distances to the nearest targets of 
50% of the regulatory proteins analyzed in hESCs (Guttman et al., 2011). For each gene of interest, specific 
HSGRL were identified and tabulated with a genomic distance between HSGRL and a putative target gene that 
is smaller than the mean value of distances to the nearest target genes regulated by the protein-coding TFs in 
hESCs. The corresponding mean values for protein-coding and lncRNA target genes were calculated based on 
distances to the nearest target genes for TFs in hESC reported by Guttman et al. (2011). In addition, the 
proximity placement metrics were defined based on co-localization within the boundaries of the same TADs 
and the placement enrichment pattern of HSNBS located near the 251 neocortex/prefrontal cortex-associated 
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genes, which identified the most significant enrichment of HSNBS placement at the genomic distances less 
than 1.5 Mb with a sharp peak of the enrichment p value at the distance of 1.5 Mb (Supplemental Figure S7).  
The assessment of conservation of HSGRL in individual genomes of 3 Neanderthals, 12 Modern 
Humans, and the 41,000-year old Denisovan genome (Reich et al., 2010; Meyer et al., 2012) was carried-out 
by direct comparisons of corresponding sequences retrieved from individual genomes and the human genome 
reference database (http://genome.ucsc.edu/Neandertal/ ). Direct access to the specific Genome Browser 
tracks utilized for analyses and visualization: 
http://genome.ucsc.edu/cgi-bin/hgTracks?db=hg18&position=chr10%3A69713986-
69714099&hgsid=393865029_yg7UixUE4a4awjjTahns4KTPkIl1 . 
Recombination rates were downloaded from the HapMap Project (The International Hapmap 
Consortium, 2007) and the numbers of DNA segments with the recombination rates of 10 cM/Mb or greater 
were counted. This threshold exceeds ~10-fold the mean intensity of recombination rates in telomeric regions, 
which were identified as the regions with the higher recombination rates in the human genome. It is well known 
that over large genomic scales, recombination rates tend to be higher in telomeric as compared to centromeric 
chromosomal regions. In telomeric regions, the mean detected hotspot spacing is 90 kb and the mean intensity 
(total rate across the hotspot) per hotspot is 0.115 cM, whereas for centromeric regions the mean spacing is 
123 kb and the mean intensity is 0.070 cM (The International Hapmap Consortium, 2007).  
 
Statistical Analyses of the Publicly Available Datasets 
All statistical analyses of the publicly available genomic datasets, including error rate estimates, background 
and technical noise measurements and filtering, feature peak calling, feature selection, assignments of 
genomic coordinates to the corresponding builds of the reference human genome, and data visualization, were 
performed exactly as reported in the original publications and associated references linked to the 
corresponding data visualization tracks (http://genome.ucsc.edu/). Any modifications or new elements of 
statistical analyses are described in the corresponding sections of the Results. Statistical significance of the 
Pearson correlation coefficients was determined using GraphPad Prism version 6.00 software. The 
significance of the differences in the numbers of events between the groups was calculated using two-sided 
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Fisher’s exact and Chi-square test, and the significance of the overlap between the events was determined 
using the hypergeometric distribution test (Tavazoie et al., 1999).  
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Figure Legends 
Figure 1. Genome-wide associations between the number of HARs and the quantity of hESC-enriched 
enhancers located within TADs.  
A. Direct correlation between the numbers of HARs and hESC-enriched enhancers located within the individual 
revTADs.  
B-D. In the hESC genome, TADs segregated into sub-groups with increasing numbers of HARs contain 
concomitantly higher proportion of hESC-enriched enhancer-harboring TADs compared with TADs without 
hESC enhancers. The fractions of TADs with and without hESC enhancers are shown for a total of 3,062 TADs 
(hg19 release of human reference genome database) in the hESC genome (B), for 1,135 TADs harboring 
2,609 HARs (C), for 2,075 TADs containing 6,703 hESC-enriched enhancers (D). In the figure (D) the average 
numbers of hESC-enriched enhancers are shown for sub-groups of TADs harboring 0; 1; 2; and at least 5 
HARs. P values designate the statistical significance of the differences of the hESC enhancer numbers 
between the neighboring sub-groups of TADs. Calculations of the HAR numbers located within TADs were 
performed after converting the genomic coordinates of 3,127 TADs (Dixon et al., 2012) from the hg18 to hg19 
release of the human reference genome database using the LiftOver algorithm.  
 
Figure 2. Markedly distinct structural features of SEs and TADs in genomes of human and mouse ESCs.  
A. Size distribution analyses revealed significantly increased size of SEs and decreased size of TADs in the 
hESC genome compared with mouse. Top two panels show the median sizes of SEs (top left panel) and TADs 
(top right panel) sorted in a descending order based on individual TAD sizes and segregated into ten sub-
groups at 10% increments. Bottom two panels show the median (bottom left panel) and average (bottom right 
panel) sizes of TADs for individual chromosomes of human and mouse ESC genomes. Note that median sizes 
of TADs on 17 of 20 (85%) chromosomes in the hESC genome (except chr7, chr13, and chr14) are smaller 
compared to median TAD sizes on chromosomes in the mESC genome.  
B. Numbers of both SEs (top left panel) and TADs (top right panel) are increased in the hESC genome 
compared with mouse. Bottom two panels illustrate that numbers of TADs are decreased in differentiated cells 
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compared to ESC both in humans (bottom left panel) and mice (bottom right panel). 
 
Figure 3. Placements of hESC enhancers and HARs within TADs are directly correlated with the size of TADs 
in the hESC genome.  
A. Significant direct correlations between the size of TADs and SE’s span defined as a number of bp between 
the two most distant SEs located within a given TAD in the hESC genome (top two panels). Top left panel 
shows a correlation profile between the size of 504 TADs and genomic span of 642 SEs located within TADs. 
Top right panel shows a correlation profile between the size of 103 TADs harboring at least two SEs and 
genomic span of 241 SEs residing within TADs. Percentiles within shaded areas indicate the percent of TADs 
containing HSGRL within a designated set, which increases concomitantly with the increasing quantity of SEs 
located within TADs and larger TAD size. Note that similar trends were observed in the mESC genome, 
however, the correlation coefficient values were not statistically significant (bottom two panels).  
B. Patterns of significant direct correlations between the size of 147 revTADs and numbers of hESC-enriched 
enhancers (top left panel) and numbers of HARs (top right panel) located within the revTADs. The bottom left 
panel illustrates the profile of significant correlation between the numbers of hESC-enriched enhancers and 
HARs residing within the revTADs (direct correlation; bottom left panel). In contrast, the bottom right panel 
shows the previously reported inverse correlation between the numbers of HSTFBS and HARs residing within 
the revTADs (Glinsky, 2016).  
C. Genome-wide, there is a highly significant direct correlation between the numbers of hESC-enriched 
enhancers located within TADs and the average size of corresponding TADs harboring hESC-enriched 
enhancers. The numbers of hESC-enriched enhancers located within each individual TAD were quantified and 
TADs harboring 0 to 9 enhancers were segregated into subgroups harboring the same numbers of enhancers. 
The numbers of TADs in each subgroup are indicated. Eighty-one TADs harboring ten or more hESC-enriched 
enhancers (range 10-30) were segregated into one subgroup with the average enhancers’ content of 12.5 per 
TAD. The average TAD sizes were computed for each subgroup of TADs and the results were plotted to 
assess the correlation pattern. 
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Figure 4. Mechanisms of HSGRL-mediated effects on principal regulatory structures of the interphase 
chromatin contributing to the evolution of genomic regulatory networks.  
Collectively, the ensemble of these structural changes facilitated by the targeted placements and retention of 
distinct families of HSGRL at specific genomic locations would enable the emergence of new SED structures 
and remodeling of existing TADs to increase the complexity and enhance the precision of genomic regulatory 
networks. See text for details and relevant references. 
 
Figure 5. Clusters of Alu elements in the vicinity of putative DNA bending sites near the borders of SEDs and 
TADs.  
A. Clusters of Alu elements near the borders of the ID3 SED on chr1:23,878,033-23,894,300 (16,268 bp). 
Dotted lines depict the genomic positions of the overlapping CTCF/cohesin-binding sites, interactions of which 
form the anchor base of the ID3 SED.  
B. Clusters of Alu elements near the NANOG SED left border on chr12:7,864,594-7,869,500 (4,907 bp).  
C. Clusters of Alu elements near the NANOG SED right border on chr12:8,012,400-8,017,400 (5,001 bp).   
Arrows in the figures (B) and )C) point the overlapping CTCF/cohesin-binding sites, interactions between which 
form the anchor base of the NANOG SED.  
Note that clusters of closely-spaced sequences of at least three Alu elements belonging to most ancient AluJ 
(~65 million years old), second oldest AluS (~30 million years old), and currently active modern AluY sub-
families are observed, suggesting that placement and/or retention of Alu elements at these sites were 
occurring for millions of years and continues at the present time (see text for details). 
 
Figure 6. Conservation patterns of HSGRL in individual human genomes.  
Conservation of HSGRL in individual genomes of 3 Neanderthals, 12 Modern Humans, and the 41,000-year 
old Denisovan genome was carried-out by direct comparisons of corresponding sequences retrieved from 
individual genomes and the human genome reference database (http://genome.ucsc.edu/Neandertal/). Full-
length sequence alignments with no gaps of the individual human genome sequences to the corresponding 
sequences in the human genome reference databases were accepted as the evidence of sequence 
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conservation in the individual human genome.  
A. Top two panels show conservation patterns of HSGRL located within the revTADs for 57 HARs and 
associated 75 CTCF-binding sites (top left panel); 22 HARs harboring 23 LMNB1-binding sites and 23 LMNB1-
binding sites residing within 22 HARs (top right panel). Bottom two panels show conservation patterns of 90 
HARs harboring 93 LMB1-binding sites (bottom left panel) and 55 HARs harboring 55 CTCF-binding sites and 
55 CTCF-binding sites located within 55 HARs (bottom right panel).  
B. Top two panels show conservation patterns of 123 HARs associated with 127 high-confidence overlapping 
CTCF/RAD21-binding sites (top left pane) and 127 high-confidence overlapping CTCF/RAD21-binding sites 
associated with 123 HARs (top right panel). Bottom two panels show conservation patterns of 69 
CTCF/RAD21-binding sites conserved in all Neandertals’ genome (bottom left panel) and 152 human-specific 
NANOG-binding sites highly-conserved in individual human genomes (bottom right panel). Note that 
conservation of all HSGRL are consistently at the lowest level in the Neanderthals’ genome, suggesting that 
creation and/or retention rates of HSGRL are enhanced in Modern Humans. However, HSGRL sequences 
manifesting the relatively high conservation levels in the Neanderthals’ genome appear most conserved in the 
individual genomes of Modern Humans as well, including the 41,000-year old Denisovan genome (bottom left 
panel). Sequences of HSGRL with assigned biochemical functions, e.g., specific TFBS or Lamin B1 (LMNB1)-
binding sites, which are residing within HARs exhibit markedly higher conservation levels compared to 
sequences of HARs harboring the corresponding HSGRL. This conclusion remains valid for HSGRL 
sequences with assigned specific biochemical or biological functions that were associated with HARs by 
proximity placement analyses (figures A, B). 
C. Direct correlations of conservation profiles of DNA sequences of distinct HSGRL in individual human 
genomes (top two panels) and markedly different values of genomic fitness scores (GFS) integrating into a 
single numerical value sequence conservation data of 909 HSGRL in individual human genomes (bottom 
panel). Note that values of GFS are inversely correlated with the variation coefficients of GFS values in 
individual human genomes, consistent with the hypothesis that GFS reflects the intrinsic property of an 
individual genome to create and/or retain the HSGRL. 
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Table 1. Association of hESC super-enhancers with human-specific regulatory loci 
Genomic Features* TADs H1 hESC-SE hsTFBS HARs 
Genome 3,062 642 3803 2745 
HARs + SE 168 212 0 406 
Enrichment Factor 1.0 6.0 NA 2.8 
HSTFBS + SE 56 72 146 0 
Enrichment Factor 1.0 6.1 2.1 NA 
HARs + HSTFBS + 
SE 
55 85 154 158 
Enrichment Factor 1.0 7.4 2.3 3.3 
SE + HSGRL 279 369 300 564 
HARs, Human Accelerated Regions; HSTFBS, human-specific Transcription Factor-Binding Sites; SE, Super 
Enhancers; HSGRL, human-specific genomic regulatory loci; H1 hESC, H1 human Embryonic Stem Cells; NA, 
not applicable; * - genomic coordinates of the hg19 human genome reference database; 
 
 
 
Table 2. Size distribution analysis of super-enhancers in human and mouse ESC 
Category hESC super-
enhancers 
 mESC super-
enhancers 
 Fold enrichment  
in hESC 
Size, bp Number Percent Number Percent  
> 30,000 29 4.2 4 1.7 7.25 
>20,000 102 14.9 28 12.1 3.64 
>10,000 331 48.4 108 46.8 3.06 
>5,000 554 81.0 154 66.7 3.60 
>2,000 683 99.9 193 83.5 3.54 
1,000-2,000 0 0.0 21 9.1 0.00 
<1,000 1 0.1 17 7.4 0.06 
Total 684 100.0 231 100.0 2.96 
hESC, human embryonic stem cells; mESC, mouse embryonic stem cells 
 
 
Table 3. Size distribution analysis of topologically-associating domains in genomes of human and mouse ESC 
Category hESC TADs  mESC TADs  Enrichment/Depletion  
in hESC 
Size, Kbp Number Percent Number Percent  
> 3,000 23 0.7 55 2.5 0.42 
>2,000 160 5.1 255 11.6 0.63 
>1,000 955 30.5 982 44.6 0.97 
>500 2154 68.9 1745 79.3 1.23 
>200 3054 97.7 2166 98.5 1.41 
>100 3125 99.9 2200 100.0 1.42 
<100 2 0.1 0 0.0 NA 
Total 3127 100.0 2200 100.0 1.42 
TADs, topologically-associating domains 
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Table 4. Estimates of creation time periods during evolution of SEs and enhancers in the hESC genome 
1.1. Estimates of super-enhancers (SE) creation time in the human ESC genome 
Number of SE in 
hESC genome 
Shared with 
mESC 
All new 
SE in 
hESC* 
New SE on 
conserved 
sequences* 
Primate-
specific SE 
sequences* 
Human-specific SE 
sequences** 
684 25 (3.7%) 659 573 83 3 
Number of new super-enhancers 
per 100,000 years 
0.88 0.76 0.11 0.81 
Number of years for creation of one 
super-enhancer 
113,636 131,579 909,091 123,457 
1.2. Estimates of enhancers' creation time in the human ESC genome 
Number of 
enhancers in 
hESC genome 
Shared with 
mESC 
All new 
enhancers*  
New enhancers 
on conserved 
sequences* 
Primate-specific 
enhancers 
sequences* 
Human-specific 
enhancers 
sequences** 
7006 682 (9.7%) 6,324 4,714 1,420 190 
Number of new enhancers per 
100,000 years 
8.4 6.3 1.9 51 
Number of years for creation of 
one enhancer 
11,905 15,873 52,632 1,961 
* Calculated based on estimates of Humans & Chimpanzees split 13 million years ago and 88 million years 
from Euarchonta & Glires (Gliriformes) split resulting in the estimated evolutionary timeline of ~75 million years; 
** Calculated based on estimates of Modern Humans & Neanderthals split 370,000 years ago; 
Estimates for human-specific SE and enhancers were calculated based on the assumption that all 
human-specific sequences emerged after Modern Humans & Neanderthals split 370,000 years ago;  
Estimates of creation time of primate-specific SE and enhancers were based on the assumption that all 
primate-specific sequences emerged before Modern Humans/Chimpanzees split 13 million years ago. 
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